Press release
Major Market Shift in Artificial Intelligence (AI) In Omics Studies Industry: Advancing Omics Research With AI-Driven Cloud Platforms And Data Federation Revolutionizing Data Sharing, Collaboration, And Insights
Artificial Intelligence (AI) In Omics Studies Market Size
The market size for artificial intelligence (AI) in omics studies has seen rapid expansion in the recent past. There is a projected increase from $0.91 billion in 2024 to $1.23 billion in 2025, which means an expected compound annual growth rate (CAGR) of 35.4%. Factors contributing to the growth during the historic period include the growing popularity of artificial intelligence, higher levels of research activities, increased incidence of chronic illnesses, escalating healthcare expenses, and its increased application in cancer.
In the coming years, the market size for artificial intelligence (AI) in omics studies is poised for exceptional growth, with a projected worth of $4.11 billion in 2029, expanding at a compound annual growth rate (CAGR) of 35.2%. The anticipated growth throughout the projected time frame can be linked to the escalating demand for customized medical treatments, an increasing need for assay assistance, the expansion of genetic and genomic data, rising investments made towards genomic research, and a boost in disposable income. Noteworthy trends expected within this period encompass advancements in AI technologies, progression of high-throughput technologies, the usage of deep learning methodologies, automated data evaluation in omics studies, and the application of predictive analytics.
What Factors Are Propelling the Expansion of the Artificial Intelligence (AI) In Omics Studies Market?
The rise in interest for customized medical treatment is predicted to boost the artificial intelligence in omics studies market's development. Customized medicine involves adapting medical care to suit each patient's distinct characteristics. Therapeutic efficacy is maximized, and negative reactions are lessened through an understanding of genetic, environmental, and lifestyle aspects. The growing implementation of personalized medicine can be attributed to advancements in genomic medicine, superior diagnostic tools, and the utilization of data in healthcare. AI's role in omics studies amplifies personalized medicine by giving a deeper understanding of diseases on a molecular level, enhancing treatment accuracy, and leading to improved patient results. For example, in October 2022, the Personalized Medicine Coalition, an American professional membership organization, reported the approval of 12 new personalized medicines, representing 34% of all newly approved therapies. This denotes a considerable growth compared to the previous years. Consequently, the rising need for personalized medicine is fuelling the expansion of the artificial intelligence in omics studies market.
Get Your Free Sample Now - Explore Exclusive Market Insights:
https://www.thebusinessresearchcompany.com/sample.aspx?id=20478&type=smp
Which Businesses Are at the Forefront of Artificial Intelligence (AI) In Omics Studies Market Development?
Major companies operating in the artificial intelligence in omics studies market are Amazon.com Inc., Hitachi Ltd., Thermo Fisher Scientific Inc., Danaher Corporation, Siemens Healthineers AG, General Electric Company, Agilent Technologies Inc., Koninklijke Philips N.V., Dassault Systemes SA, Illumina Inc., Fujifilm Holdings Corporation, Shimadzu Corporation, Waters Corporation, Bio-Rad Laboratories Inc., Canon Medical Systems Corporation, Bruker Corporation, Qiagen N.V., BGI Genomics Co Ltd., Takara Bio Inc., Elekta AB
Which Businesses Are at the Forefront of Market Development?
Leading businesses existing within the artificial intelligence in omics studies market are concentrating on innovating superior solutions like cloud-based platforms, utilizing data federation concepts to boost data collaboration and sharing across diverse research institutes, thereby allowing the smooth amalgamation and examination of extensive omics data procured from myriad sources while assuring data seclusion and security. These cloud-based platforms amalgamate several omics data types, such as genomics, proteomics, and metabolomics and make use of machine learning algorithms to study the data and generate insights. To exemplify, DNAstack, a biotechnology company based in Canada, introduced Omics AI, a groundbreaking software suite aimed at propelling omics research, in September 2023. Omics AI's unique features include its capacity to process large datasets, render real-time analytics, and promote global researcher collaboration. While this development elevates omics studies' effectiveness, it also highlights apprehensions over data privacy and emphasizes the necessity for powerful cybersecurity procedures to shield sensitive genetic data.
How Is the Artificial Intelligence (AI) In Omics Studies Market Segmented?
The artificial intelligence (AI) in omics studies market covered in this report is segmented -
1) By Offering: Software, Services
2) By Technology Platform: Sequencing, Epigenomics, Proteomics, Metabolomics, Other Technologies
3) By Application: Oncology, Infectious Diseases, Neurology, Cardiovascular Diseases, Immunology, Other Applications
4) By End-User: Academic And Research Institutes, Biopharmaceutical Company, Other End-Users
Subsegments:
1) By Software: AI-Powered Data Analytics Software, Omics Data Integration Software, Machine Learning Platforms for Genomics, AI-Based Protein Structure Prediction Software, AI-Based Drug Discovery Software, AI for Metabolomics Analysis Tools, AI-Driven Genome Sequencing Software, Bioinformatics Software for Multi-Omics Data
2) By Services: AI-Based Data Analysis Services, Consulting Services for AI in Omics, AI Model Development and Customization Services, Omics Data Management and Interpretation Services, AI-Driven Drug Discovery and Development Services, Cloud-Based Omics Data Storage and Processing Services, AI-Based Omics Training and Support Services
Pre-Book Your Report Now For A Swift Delivery:
https://www.thebusinessresearchcompany.com/report/artificial-intelligence-ai-in-omics-studies-global-market-report
Where Is the Artificial Intelligence (AI) In Omics Studies Market Growth Most Prominent?
North America was the largest region in the artificial intelligence in omics studies market in 2024. Europe is expected to be the fastest-growing region in the forecast period. The regions covered in the artificial intelligence in omics studies market report are Asia-Pacific, Western Europe, Eastern Europe, North America, South America, Middle East, Africa.
What Is Covered In The Artificial Intelligence (AI) In Omics Studies Global Market Report?
- Market Size Analysis: Analyze the artificial intelligence (ai) in omics studies Market Size by key regions, countries, product types, and applications.
- Market Segmentation Analysis: Identify various subsegments within the artificial intelligence (ai) in omics studies market for effective categorization.
- Key Player Focus: Focus on key players to define their market value, share, and competitive landscape.
- Growth Trends Analysis: Examine individual growth trends and prospects in the Market.
- Market Contribution: Evaluate contributions of different segments to the overall artificial intelligence (ai) in omics studies market growth.
- Growth Drivers: Detail key factors influencing market growth, including opportunities and drivers.
- Industry Challenges: Analyze challenges and risks affecting the artificial intelligence (ai) in omics studies market.
- Competitive Developments: Analyze competitive developments, such as expansions, agreements, and new product launches in the market.
Unlock Exclusive Market Insights - Purchase Your Research Report Now!
https://www.thebusinessresearchcompany.com/purchaseoptions.aspx?id=20478
Connect with us on:
LinkedIn: https://in.linkedin.com/company/the-business-research-company,
Twitter: https://twitter.com/tbrc_info,
YouTube: https://www.youtube.com/channel/UC24_fI0rV8cR5DxlCpgmyFQ.
Contact Us
Europe: +44 207 1930 708,
Asia: +91 88972 63534,
Americas: +1 315 623 0293 or
Email: mailto:info@tbrc.info
Learn More About The Business Research Company
With over 15,000+ reports from 27 industries covering 60+ geographies, The Business Research Company has built a reputation for offering comprehensive, data-rich research and insights. Our flagship product, the Global Market Model delivers comprehensive and updated forecasts to support informed decision-making.
This release was published on openPR.
Permanent link to this press release:
Copy
Please set a link in the press area of your homepage to this press release on openPR. openPR disclaims liability for any content contained in this release.
You can edit or delete your press release Major Market Shift in Artificial Intelligence (AI) In Omics Studies Industry: Advancing Omics Research With AI-Driven Cloud Platforms And Data Federation Revolutionizing Data Sharing, Collaboration, And Insights here
News-ID: 3873196 • Views: …
More Releases from The Business Research Company
Segment Evaluation and Major Growth Areas in the Personalized Testing and Supple …
The personalized testing and supplements sector is gaining remarkable traction, driven by advancements in technology and a rising consumer focus on tailored health solutions. As more individuals seek customized wellness options, this market is set to experience substantial expansion in the coming years. Here's an in-depth look at its current valuation, key players, significant trends, and the main market segments shaping its future.
Market Valuation and Expansion Forecast for Personalized Testing…
Top Players and Market Competition in the Skin Microbiome Industry
The skin microbiome market is emerging as a significant area of interest due to growing awareness about the critical role of skin health and innovative skincare technologies. As research advances and consumer preferences shift towards more natural and science-backed products, this market is set to undergo substantial growth. Let's explore the current market size, key players, driving factors, and upcoming trends shaping the skin microbiome industry.
Projected Expansion in the Skin…
Key Strategic Developments and Emerging Changes Shaping the Upadacitinib Market …
The upadacitinib market is poised for significant expansion over the coming years, driven by advances in treatment options and increasing awareness of autoimmune diseases. This report delves into the market's current size, key drivers, major players, and the emerging trends shaping its future trajectory.
Steady Growth Expected in Upadacitinib Market Size Through 2029
The market for upadacitinib is projected to reach $2.54 billion by 2029, growing at a robust compound annual…
Analysis of Key Market Segments Driving the Alzheimer's Disease Diagnostic Marke …
The Alzheimer's disease diagnostic sector is rapidly evolving as advancements in technology and healthcare infrastructure open new possibilities for early detection and personalized treatment. With rising awareness and innovative approaches, this market is poised for significant growth in the coming years. Let's explore the current market size, key drivers, leading companies, and emerging trends that are shaping this critical healthcare field.
Projected Market Size and Growth Trends in Alzheimer's Disease Diagnostics…
More Releases for Omics
Single-Cell Omics Market to Reach USD 10.74 Billion by 2030 as Multi-Omics & Pre …
Sub-Headline: The global Single-Cell Omics Market is expected to grow from USD 4.12 billion in 2023 to USD 10.74 billion by 2030, registering a robust CAGR of 14.6%, driven by rapid advances in single-cell sequencing, spatial omics, immunology research, and multi-omics integration.
Introduction
The Single-Cell Omics Market is undergoing explosive expansion as researchers seek deeper insights into cellular diversity, gene expression variability, epigenetic signatures, and molecular activity at single-cell resolution. Unlike bulk…
Emerging Single-Cell Omics Market Trends: Product Innovation Marks A Milestone I …
Use code ONLINE30 to get 30% off on global market reports and stay ahead of tariff changes, macro trends, and global economic shifts.
Single-Cell Omics Market Size Growth Forecast: What to Expect by 2025?
The size of the single-cell omics market has experienced rapid expansion in the last few years. From the year 2024 to 2025, an increase from $2.08 billion to $2.39 billion is projected, with an anticipated compound annual growth…
Rising Cancer Prevalence Propels Growth In The Single-Cell Omics Market: An Emer …
The Single-Cell Omics Market Report by The Business Research Company delivers a detailed market assessment, covering size projections from 2025 to 2034. This report explores crucial market trends, major drivers and market segmentation by [key segment categories].
What Is the Projected Growth of the Single-Cell Omics Market?
In recent times, there has been a significant expansion in the size of the single-cell omics market. It is predicted to increase from $2.08 billion…
Rising Prevalence Of Genetic Illnesses Drives Growth Of The Spatial Omics Market …
What combination of drivers is leading to accelerated growth in the spatial omics market?
The rising prevalence of genetic disorders is expected to drive the spatial omics market. Genetic diseases are caused by abnormalities in DNA and are increasing due to better awareness and diagnostic technologies. Spatial omics provides in-depth molecular and genetic maps, helping study these disorders. For instance, the World Health Organization (WHO) estimated that congenital diseases caused 240,000…
Prominent Single-Cell Omics Market Trend for 2025: Product Innovation Marks A Mi …
What industry-specific factors are fueling the growth of the single-cell omics market?
The escalation in the occurrence of cancer is forecasted to boost the expansion of the single-cell omics market in the future. Cancer includes various diseases that occur when irregular cells multiply uncontrollably, overstep their usual limits, and either metastasize to other organs or infiltrate nearby body parts in almost any organ or tissue. The detection of biomarkers for cancer…
Charnwood Discovery and Intelligent Omics Announce Strategic Collaboration
Charnwood Discovery a leading drug discovery research partner has announced a strategic collaboration with Intelligent OMICS Ltd (Intellomx) who specialise in applying artificial intelligence (AI) and Machine Learning (ML) to accelerate drug discovery.
The collaboration will enable Charnwood Discovery to enhance its already extensive drug discovery services through Intellomx's AI platform which enables the identification of previously unattainable targets.
Dr Francesca Sadler, Charnwood Discovery's Chief Commercial Officer commented:
"This exciting collaboration…
